At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
TCDA Tricida Inc.
Delisted 11-15 19:41:48 EST
0.1080
+0.0000
0.00%
High0.1080
Low0.1080
Vol0.00
Open0.1080
D1 Closing0.1080
Amplitude0.00%
Mkt Cap6.27M
Tradable Cap5.50M
Total Shares58.03M
T/O3.19M
T/O Rate0.00%
Tradable Shares50.89M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Tricida, Inc. (NASDAQ:TCDA) Position Cut by Victory Capital ...
BRIEF-Tricida - On December 19, 2022, Tricida Received An Additional Letter From Patheon Referencing The Purported Termination Notice From December 7, 2022
↕️ Tricida and Vaxcyte are having very different Mondays
$PCVX skyrockets +66% after reporting promising data for its lead vaccine candidate in pneumococcal diseases.
$TCDA plunges -94% after a study of its kidney disease drug missed its main goal.
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of TRC101, a non-absorbed orally-administered polymer that has completed phase 3 trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company was incorporated in 2013 and is headquartered in South San Francisco, California.